Obesity and ultrasound-estimated visceral fat deposits in women undergoing Assisted Reproductive Technology (ART) procedures

References

• Lashen H, Ledger W, Bernal AL, et al. Extremes of body mass do not adversely affect the outcome of superovulation and in-vitro fertilization. Hum Reprod 1999;14:712–15
   PubMed Web of Science ®Google Scholar
• Fedorcsák P, Dale PO, Storeng R, et al. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 2004;19:2523–8
   PubMed Web of Science ®Google Scholar
• Bellver J, Mifsud A, Grau N, et al. Similar morphokinetic patterns in embryos derived from obese and normoweight infertile women: a time-lapse study. Hum Reprod 2013;28:794–800
   PubMed Web of Science ®Google Scholar
• Koning AM, Kuchenbecker WK, Groen H, et al. Economic consequences of overweight and obesity in infertility: a framework for evaluating the costs and outcomes of fertility care. Hum Reprod Update 2010;16:246–54
   PubMed Web of Science ®Google Scholar
• Veleva Z, Tiitinen A, Vilska S, et al. High and low BMI increase the risk of miscarriage after IVF/ICSI and FET. Hum Reprod 2008;23:878–84
   PubMed Web of Science ®Google Scholar
• Maheshwari A, Stofberg L, Bhattacharya S. Effect of overweight and obesity on assisted reproductive technology – a systematic review. Hum Reprod Update 2007;13:433–44
   PubMed Web of Science ®Google Scholar
• Machtinger R, Combelles CM, Missmer SA, et al. The association between severe obesity and characteristics of failed fertilized oocytes. Hum Reprod 2012;27:3198–207
   PubMed Web of Science ®Google Scholar
• Valckx SD, De Pauw I, De Neubourg D, et al. BMI-related metabolic composition of the follicular fluid of women undergoing assisted reproductive treatment and the consequences for oocyte and embryo quality. Hum Reprod 2012;27:3531–9
   PubMed Web of Science ®Google Scholar
• Valckx SD, Arias-Alvarez M, De Pauw I, et al. Fatty acid composition of the follicular fluid of normal weight, overweight and obese women undergoing assisted reproductive treatment: a descriptive cross-sectional study. Reprod Biol Endocrinol 2014;12:13
   PubMed Web of Science ®Google Scholar
• Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548–56
   PubMed Web of Science ®Google Scholar
• Lopes HF, Corrêa-Giannella ML, Consolim-Colombo FM, et al. Visceral adiposity syndrome. Diabetol Metab Syndr 2016;8:40
   PubMed Web of Science ®Google Scholar
• Schlecht I, Fischer B, Behrens G, et al. Relations of visceral and abdominal subcutaneous adipose tissue, body mass index, and waist circumference to serum concentrations of parameters of chronic inflammation. Obes Facts 2016;9:144–57
   PubMed Web of Science ®Google Scholar
• Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004;114:1752–61
   PubMed Web of Science ®Google Scholar
• Keaney JF Jr, Larson MG, Vasan RS, et al. Framingham Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003;23:434–9
   PubMed Web of Science ®Google Scholar
• Salmon AB. Beyond diabetes: does obesity-induced oxidative stress drive the aging process? Antioxidants (Basel) 2016;5:24. doi: 10.3390/antiox5030024
   Google Scholar
• Suzuki R, Watanabe S, Hirai Y, et al. Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen. Am J Med 1993;95:309–14
   PubMed Web of Science ®Google Scholar
• Ciavattini A, DI Giuseppe J, Clemente N, et al. Thickness of preperitoneal fat as a predictor of malignancy in overweight and obese women with endometrial polyps. Oncol Lett 2016;11:2278–82
   PubMed Web of Science ®Google Scholar
• Stolk RP, Wink O, Zelissen PM, et al. Validity and reproducibility of ultrasonography for the measurement of intra-abdominal adipose tissue. Int J Obes Relat Metab Disord 2001;25:1346–51
   PubMed Web of Science ®Google Scholar
• Borm G, Mannaerts B. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum Reprod 2000;15:1490–8. Erratum in: Hum Reprod 2000;15:1877
   PubMed Web of Science ®Google Scholar
• Prados FJ, Debrock S, Lemmen JG, et al. The cleavage stage embryo. Hum Reprod 2012;27:i50–71
   PubMed Web of Science ®Google Scholar
• Lin YC, Chang SY, Lan KC, et al. Human oocyte maturity in vivo determines the outcome of blastocyst development in vitro. J Assist Reprod Genet 2003;20:506–12
   PubMed Web of Science ®Google Scholar
• Van Royen E, Mangelschots K, De Neubourg D, et al. Characterization of a top quality embryo, a step towards single-embryo transfer. Hum Reprod 1999;14:2345–9
   PubMed Web of Science ®Google Scholar
• Setsukinai K, Urano Y, Kakinuma K, et al. Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem 2003;278:3170–5
   PubMed Web of Science ®Google Scholar
• Raffaelli F, Vignini A, Giulietti A, et al. In vitro effects of resveratrol on oxidative stress in diabetic platelets. Acta Diabetol 2014;51:61–9
   PubMed Web of Science ®Google Scholar
• Luke B, Brown MB, Stern JE, SART Writing Group, et al. Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates. Hum Reprod 2011;26:245–52
   PubMed Web of Science ®Google Scholar
• La Vignera S, Condorelli R, Bellanca S, et al. Obesity is associated with a higher level of pro-inflammatory cytokines in follicular fluid of women undergoing medically assisted procreation (PMA) programs. Eur Rev Med Pharmacol Sci 2011;15:267–73
   PubMed Web of Science ®Google Scholar
• Revelli A, Delle Piane L, Casano S, et al. Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reprod Biol Endocrinol 2009;7:40
   PubMed Web of Science ®Google Scholar
• Mendoza C, Ruiz-Requena E, Ortega E, et al. Follicular fluid markers of oocyte developmental potential. Hum Reprod 2002;17:1017–22
   PubMed Web of Science ®Google Scholar
• Robker RL, Wu LL, Yang X. Inflammatory pathways linking obesity and ovarian dysfunction. J Reprod Immunol 2011;88:142–8
   PubMed Web of Science ®Google Scholar
• Gleicher N, Kushnir VA, Albertini DF, Barad DH. Improvements in IVF in women of advanced age. J Endocrinol 2016;230:F1–6
   PubMed Web of Science ®Google Scholar